Food and Drug Administration approved the once to weekly semaglutide injection for chronic weight management in adults with a body mass index of 27 or greater, along with at least one other obesity related comorbidity such as high cholesterol or type 2 diabetes
PlexusDx Precision Peptide Genetic Test identifies your variants in GIPR, FTO, and MC4R, which influence your individual response to semaglutide and metabolic stress during surgery
Digital engagement and enhanced outcomes A 2025 retrospective study found that digital engagement, including app-based tracking, coaching, and community support, significantly enhanced weight loss outcomes in adults treated with tirzepatide
your lifestyle, gut repair, hormone balance, muscle quality, detoxification, and circadian rhythm walk you through the door. From Functional Medicine to FM 2.0 If Functional Medicine 1.0 was about finding the root causes of illness, Functional Medicine 2.0 is about rebuilding the body's communication networks so it can stay well